O Hadassah Academic College in Jerusalem, the course on “Entrepreneurship in Medicinal Cannabis” will open next semester and places are already sold out. About 90 students will study the six thousand years of the history of Cannabis Sativa L., before delving into the chemistry of the plant, its legality, its various uses and different methods of consumption.
The course syllabus also includes the medicinal potential of cannabis, from oncology, neurology and psychiatry to pain management, the adverse effects of consumption and driving under the influence of cannabis, the latest research and investigation, the black market, the distribution and use of cannabis in food supplements and cosmetics, among others.
A news was advanced by the University's own website and cited in an article by the forward. Various professionals and experts such as doctors, farmers, lawyers and even patients will be invited to give lectures to the students, explained Michael Dor, director of the University of Hadassah, who for the last four years has been the main adviser in the field of medical cannabis, under the under the Israeli Ministry of Health. “The aim of the course is to teach as much as possible, in all locations, about medical cannabis,” said Michael Dor.
Students enrolled in the course come from fields as diverse as lecturers and professors and may be entering higher education, be young graduates or professionals in related fields. “Partnerships will be established between farmers, doctors and lawyers. Groups will be formed that will then continue to work together”, said Dor, who also stressed that “our strong point is cooperation, bringing together professionals from different areas. It is a very integrated course with immense perspectives”.
[perfectpullquote align=”right” cite=”” link=”” color=”” class=”” size=””]”Various professionals and specialists such as doctors, farmers, lawyers and even patients will be invited to give lectures to students ”[/perfectpullquote]
Some classes will even be given by medical cannabis patients and their doctors, who will talk about their experience, the advantages and difficulties of cannabis treatment. The course will address how cannabis can help with various conditions and conditions, such as post-traumatic stress disorder, autism, fibromyalgia, psoriasis, drug-resistant epilepsy in children, muscle and bone disorders, irritable bowel syndrome and other chronic pain. But Michael Dor wants to present a balanced approach, so he's already invited a psychiatrist to give a presentation against cannabis use and its less favorable side effects.
“All those who leave this course, after graduation, will go to their area to implement knowledge. Farmers, lawyers, entrepreneurs, doctors who treat patients, each of our students will get that knowledge and use it,” continues Dor. “The information provided through the course influences not only the students, but also those they will eventually work with. Indirectly, this course can educate the Israeli public more broadly,” she says.
Contrary to what one might think, the “Entrepreneurship in Medicinal Cannabis” course has not yet met with negative reviews or generated controversy. “There is a stigma around cannabis, but these days I have a new problem: I have to convince people that cannabis is not a cure-all in the world.” shoots with a sense of humor Dr. Ache. "It's a sexy area."
Bertold Fridlender, president of the University, also told Forward that “Israel’s medical cannabis development is one of the most advanced in the world, and we felt it would be important to offer, through our institution, this kind of expertise for something that really offers employment in our country.” The University of Hadassah is “a career-oriented school that focuses on helping students find employment after graduation. Some students may want to work in the cannabis industry,” explains Fridlender.
[perfectpullquote align=”left” cite=”” link=”” color=”” class=”” size=””]“There is a stigma around cannabis, but nowadays the problem is convincing people that cannabis It's not the cure-all. It's a sexy area”[/perfectpullquote]
Israel is the leading country in medical cannabis research and research, largely thanks to the discoveries of renowned Israeli chemist Raphael Mechoulam in the early XNUMXs, who described the plant's main psychoactive component, THC, and later discovered the endocannabinoid system.
Legal since 1998, the medical cannabis program has more than 30 patients in Israel. While recreational use remains illegal, cannabis is widely respected scientifically, medicinally, biotechnologically, agriculturally and even academically. Unlike in the US, where cannabis remains, under federal law, illegal (despite state policies and regulations), in Israel the government encourages growers, scientists, researchers, technology professionals and doctors to collaborate and advance in the field of medical cannabis.
Featured Photo: All Rights Reserved
Luxembourg: new government freezes cannabis legalization
Luxembourg's ambitious plan for the full legalization of recreational cannabis markets has been put on hold by the new government...
Europol and EMCDDA report warns of trafficking problems. Cannabis market in Europe is worth more than 11.4 billion a year
A joint analysis by EMCDDA and Europol, entitled “EU Drug Market: Cannabis”, released last week, warns that the market...
Syqe Air approved in Australia as a medical device. Israeli company could be bought by Phillip Morris for more than 600 million dollars
Syqe Medical announced that its vaporizer, Syqe Air, has been approved by Australian health authorities as a medical device....
Australia: Medical Association warns of risks of recreational cannabis use
In a context of intense debates about the legalization of recreational cannabis in Australia, the Australian Medical Association (AMA) submitted a...
Italy: Researchers find evidence of cannabis use in the XNUMXth century in Milan
Archaeotoxicological discoveries have revealed the recreational use of cannabis in XNUMXth century Europe. Analysis of bones from hospital patients...
Cannadouro returns to Alfândega do Porto next weekend
It is definitely the meeting place for cannabis culture in Portugal. On the 18th and 19th of November this year,...
Organigram receives strategic investment of 124,6 million from British American Tobacco
Organigram Holdings Inc., a Canadian cannabis producer, announced a strategic investment of 124,6 million Canadian dollars from...
Germany: Legalization may only happen in 2024, with postponement of the vote in the Bundestag
Advances in legislation to regulate cannabis in Germany have suffered yet another delay. According to MarijuanaMoment, the vote...
Sidarta Ribeiro winks at Baudelaire with “As Flores do Bem”
The renowned Brazilian scientist, Sidarta Ribeiro, recently released a book that promises to challenge prejudices about cannabis and contribute to...
Portugal: Prime Minister, António Costa, resigns over suspicions of corruption
The Prime Minister of Portugal, António Costa, presented his resignation to the President of the Republic, Marcelo Rebelo de Sousa, this afternoon, in...